Hyliion Holdings Corp. (HYLN) Key Metrics
HYLN valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $544.7M
- Enterprise value
- $678.3M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 58.9 10-yr median 207.3
- Price / book
- 4.4 10-yr median 1.7
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- 3.57
HYLN key metrics, 2018–2025
Fiscal year ended December 31, 2025 · U.S. dollarsHYLN valuation Price multiples at each fiscal year-end price.
HYLN returns How much profit the business earns on the capital it uses.
HYLN per-share figures Results divided by the shares outstanding at year-end.
HYLN financial health Debt, liquidity and how easily interest is covered.
HYLN efficiency & capital use Working capital cycle and where the cash goes.
HYLN valuation history
HYLN returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
HYLN debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
HYLN cash returned to shareholders
HYLN price vs earnings per share
HYLN key metrics
2018–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||
| Market capitalization | $322.8M | $456.5M | $147.7M | $410.4M | $1.07B | — | $865.6M | — |
| Enterprise value | $234.8M | $343.2M | −$7.9M | $104.5M | $699.2M | — | $881.4M | — |
| Price / sales | 92.9 | 302.5 | 219.7 | 194.9 | — | — | — | — |
| Price / book | 1.7 | 1.9 | 0.5 | 1.0 | 1.9 | — | — | — |
| EV / sales | 67.6 | 227.4 | -11.7 | 49.6 | — | — | — | — |
| Earnings yield | −17.7% | −11.4% | −83.6% | −37.4% | −9.0% | — | −1.6% | — |
| Free cash flow yield | −21.8% | −16.0% | −84.2% | −32.7% | −7.8% | — | −1.3% | — |
| Shareholder yield (dividends + buybacks) | 0.0% | 3.1% | 0.0% | 0.0% | 0.0% | — | — | — |
| Share price at fiscal year-end | $1.84 | $2.61 | $0.81 | $2.34 | $6.20 | $16.48 | $9.99 | — |
| Per share | ||||||||
| Revenue per share | $0.02 | $0.01 | $0.00 | $0.01 | $0.00 | — | $0.00 | — |
| Earnings per share | −$0.33 | −$0.30 | −$0.68 | −$0.87 | −$0.56 | — | −$0.16 | — |
| Operating cash flow per share | −$0.27 | −$0.32 | −$0.64 | −$0.67 | −$0.47 | — | −$0.13 | — |
| Free cash flow per share | −$0.40 | −$0.42 | −$0.69 | −$0.77 | −$0.48 | — | −$0.13 | — |
| Cash per share | $0.53 | $0.69 | $0.90 | $1.79 | $2.19 | — | $0.07 | — |
| Book value per share | $1.09 | $1.40 | $1.69 | $2.41 | $3.22 | — | −$0.21 | — |
| Tangible book value per share | $1.09 | $1.40 | $1.69 | $2.41 | $3.22 | — | −$0.21 | — |
| Capex per share | $0.14 | $0.09 | $0.04 | $0.10 | $0.01 | — | $0.00 | — |
| Debt per share | $0.02 | $0.04 | $0.04 | $0.04 | $0.05 | — | $0.26 | — |
| Shares outstanding | 175.4M | 174.9M | 181.4M | 175.4M | 172.2M | — | 86.6M | — |
| Change in shares outstanding | +0.3% | −3.6% | +3.4% | +1.8% | — | — | — | — |
| Returns & profitability | ||||||||
| Return on equity (ROE) | −26.2% | −18.9% | −33.8% | −31.4% | −16.1% | 104.2% | — | −2.4% |
| Return on invested capital (ROIC) | −43.7% | −36.1% | −80.9% | −82.9% | −63.1% | −82.1% | — | — |
| Return on assets (ROA) | −24.5% | −17.6% | −31.9% | −29.9% | −15.6% | 96.9% | −194.7% | −0.1% |
| Return on tangible assets | −28.1% | −19.8% | −37.6% | −34.3% | −16.6% | 49.5% | −103.3% | — |
| Income quality (OCF / net income) | — | — | — | — | — | −0.07 | — | — |
| Financial health | ||||||||
| Total debt | $4.4M | $6.8M | $7.6M | $7.3M | $8.6M | $6.8M | $22.2M | $61,430 |
| Cash & short-term investments | $92.4M | $120.1M | $163.2M | $313.2M | $377.2M | $591.6M | $6.3M | $1.1M |
| Net debt | −$88.0M | −$113.4M | −$155.5M | −$305.9M | −$368.6M | −$584.8M | $15.9M | −$1.0M |
| Debt / equity | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 | — | 2.52 |
| Debt / assets | 0.02 | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 1.57 | 0.15 |
| Net debt / EBITDA | — | — | — | — | — | −1.76 | — | — |
| Current ratio | 10.00 | 9.17 | 12.02 | 22.08 | 25.37 | 69.89 | 0.55 | 4.17 |
| Quick ratio | 10.00 | 9.17 | 12.02 | 22.08 | 25.36 | 69.87 | 0.54 | 3.82 |
| Interest coverage | — | — | — | -28.0 | — | -4.1 | -3.7 | — |
| Working capital | $88.8M | $116.7M | $166.6M | $309.5M | $371.2M | $603.6M | −$5.5M | $1.2M |
| Invested capital | $104.0M | $131.0M | $150.7M | $117.7M | $185.3M | $55.3M | −$2.2M | −$1.0M |
| Tangible asset value | $192.0M | $244.4M | $306.3M | $423.4M | $553.7M | $639.8M | −$18.5M | −$501,591 |
| Net current asset value | $87.1M | $112.4M | $159.6M | $301.0M | $362.0M | $597.4M | −$25.3M | $1.2M |
| Graham net-net per share | $0.46 | $0.59 | $0.78 | $1.66 | $2.05 | — | −$0.30 | — |
| Capital allocation | ||||||||
| Share buybacks (net) | $0 | $14.0M | $33,000 | $157,000 | $0 | $0 | — | — |
| Capex / revenue | 683.2% | 1,095.1% | 1,101.3% | 822.1% | 1,190.0% | — | — | — |
| Capex / depreciation | 3.99 | 5.25 | 2.11 | 14.11 | 2.69 | 0.37 | 0.34 | 0.78 |
| Stock-based compensation / revenue | 157.6% | 305.8% | 925.1% | 331.4% | 2,461.0% | — | — | — |
| R&D / revenue | 1,063.8% | 100.0% | 12,238.1% | 5,240.7% | 29,130.5% | — | — | — |
| SG&A / revenue | 654.9% | 1,615.8% | 6,340.9% | 1,993.7% | 17,649.5% | — | — | — |
| Efficiency | ||||||||
| Days sales outstanding | 126.7 | 237.4 | 319.4 | 104.5 | 147.8 | — | — | — |
| Days of inventory on hand | — | — | 7.9 | 3.9 | 16.4 | 27.1 | 20.6 | — |
| Days payables outstanding | 165.2 | 1,221.0 | 747.0 | 213.2 | 623.1 | 312.7 | 233.7 | — |
| Cash conversion cycle (days) | -38.6 | -983.6 | -419.8 | -104.8 | -458.9 | — | — | — |
| Receivables turnover | 2.88 | 1.54 | 1.14 | 3.49 | 2.47 | 0.00 | 0.00 | 0.00 |
| Payables turnover | 2.21 | 0.30 | 0.49 | 1.71 | 0.59 | 1.17 | 1.56 | — |
| Inventory turnover | — | — | 46.38 | 93.38 | 22.25 | 13.47 | 17.73 | — |
| Asset turnover | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average receivables | $1.2M | $981,500 | $588,000 | $603,000 | $81,000 | $118,500 | $131,000 | $117,000 |
| Average payables | $4.2M | $4.7M | $3.5M | $5.1M | $4.7M | $1.5M | $1.5M | $1.8M |
| Average inventory | — | — | $37,000 | $94,000 | $123,000 | $132,000 | $132,000 | $132,000 |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 3.0% | 131.5% |
Computed from HYLN's annual financial statements (latest annual report filed February 25, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
HYLN valuation and financial ratios
Hyliion earned a return on equity of −26.2% and a return on invested capital of −43.7% in fiscal 2025. It ended the year with $4.4 million of debt and $92.4 million in cash and short-term investments, a net cash position of $88.0 million.
See the HYLN income statement, the HYLN chart for price history, or the HYLN stock overview for the latest quote and news.
HYLN key metrics FAQ
What is Hyliion's return on equity?
Hyliion's return on equity (ROE) was −26.2% in fiscal 2025: net income of -$57.2 million on average shareholders' equity of $218.2 million.
What is Hyliion's ROIC?
Hyliion's return on invested capital was −43.7% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Hyliion have?
Hyliion had total debt of $4.4 million at the end of fiscal 2025, a debt-to-equity ratio of 0.02 and more cash than debt.
What is Hyliion's free cash flow yield?
Hyliion generated -$70.3 million of free cash flow in fiscal 2025, a free cash flow yield of −21.8% on its market value at year-end ($322.8 million).
What is Hyliion's current ratio?
Hyliion's current ratio was 10.00 at the end of fiscal 2025: current assets were 10.00 times current liabilities.